Taiwan's Academic Sinica has synthesized monoclonal antibodies that are able to identify the protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), an important step in the direction of producing a rapid screening reagent for the fast spreading pathogenic virus.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Exhibition celebrates shared memories between Taipei, Shanghai
12/22/2024 09:04 PM - Society
Health ministry previews tighter betel nut regulations
12/22/2024 08:46 PM - Culture
Taiwan gears up for Christmas with festive events
12/22/2024 08:28 PM - Politics
Taipei 101 lights up to celebrate 90th anniversary of ROC-Guatemala ties
12/22/2024 07:51 PM - Culture
Taiwan Lantern Festival to feature baseball following historic win
12/22/2024 06:26 PM